5 takeaways from RFK Jr.’s first confirmation hearing as Trump’s nominee for health secretary
Robert F. Kennedy Jr. was pressed to clarify his views on vaccines, abortion, and public health priorities in his first ...
WPLG21m
Certain Lay’s potato chips considered ‘high risk’ according to FDA recall
The U.S. Food & Drug Administration has recalled a popular brand of potato chips saying the product may be high risk for some ...
The American Journal of Managed Care41m
FDA-Approved IV Iron Formulations
Panelists discuss how modern FDA-approved intravenous iron formulations, including ferric carboxymaltose, ferumoxytol, and ...
MLive46m
Lay’s potato chip recall now elevated to FDA’s highest-risk level
The FDA has upgraded a recall of Lay’s Potato Chips to the highest level possible, meaning consuming the chips will cause ...
Healio3h
Decentralized clinical trials: FDA guidance and the ‘new modus operandi’
The COVID-19 pandemic forced investigators conducting clinical trials to use decentralized elements, such as telehealth, to ...
Kava Growers In Hawaiʻi Fear Being Associated With ‘Gas Station Heroin’
Hawaiʻi lawmakers are considering regulating kratom and banning sales to minors. But kava advocates want an outright ban.
soapcentral4h
Why did FDA set Walmart's Broccoli Recall to Class I? Deadly reason explored
The Food and Drug Administration has updated the recall of Broccoli florets sold at Walmart to class I risk level, which is the highest level of risk.
Grist on MSN4h
Lab-grown meat rebrands itself to woo Trump — and RFK Jr.
The chicken before me had neither lived nor died, but it did look really tasty. Five stories up, in a sunny event space ...
FDA approves medication for sleep apnea
The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence ...
FierceBiotech6h
Takeda axes failed epilepsy asset after FDA weighs in on data package
Takeda has axed plans to seek approval for its failed epilepsy drug candidate soticlestat. The Japanese drugmaker pulled the plug on the program after the FDA pointed out the shortcomings of its ...
Halted research, disciplined doctors: internal audit finds Kaiser ignored patient protections in California study
Two top clinicians have been disciplined amid growing concern that Kaiser’s system for monitoring research safety and ethics ...
McKnight's Long-Term Care News8h
FDA expands Ozempic to treat kidney disease in people with diabetes
The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes and chronic kidney disease (CKD). The drug is now indicated specifically to treat kidney failure, ...